Home Newsfeeds Orchard Therapeutics Q2 EPS $(0.04) Up From $(0.29) YoY

Orchard Therapeutics Q2 EPS $(0.04) Up From $(0.29) YoY

Orchard Therapeutics (NASDAQ:ORTX) reported quarterly losses of $(0.04) per share. This is a 86.21 percent increase over losses of $(0.29) per share from the same period last year.

byBenzinga Newsdesk

August 4, 2022

1 minute read

Orchard Therapeutics (NASDAQ:ORTX) reported quarterly losses of $(0.04) per share. This is a 86.21 percent increase over losses of $(0.29) per share from the same period last year.

TC Energy’s NGTL Pipeline Faces Pressure Reduction Order Despite Repaired Rupture: Report

By Lekha Gupta

May 15, 12:53 PM

Canada Energy Regulator orders TC Energy Corp's NGTL to reduce pipeline pressure. No service interruption expected. Investigation ongoing.

ATMP

Investor Caution – Medtronic’s Rocky Road Ahead For Hypertension Device

By Vandana Singh

August 24, 2:20 PM

The FDA Circulatory System Devices Panel vote was closely divided on the benefit/risk profile of Medtronic Plc's (NYSE: MDT) device (tied at 6-6 and one abstention), with the panel chair breaking the tie, resulting in a final 6-7 vote, recommending against the approval of the blood pressure treat

MDT